These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 22202322)

  • 1. [A case of breast cancer liver metastases responding to lapatinib and capecitabine therapy].
    Sato T; Nakagawa T; Kuwayama T; Oda G; Sugimoto H; Ishiba T; Sugihara K
    Gan To Kagaku Ryoho; 2011 Nov; 38(12):2180-2. PubMed ID: 22202322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Two cases of HER2-positive advanced or metastatic breast cancer, responding to lapatinib and capecitabine].
    Nakamura Y; Aono T; Nomura M; Iwase K; Tanaka Y
    Gan To Kagaku Ryoho; 2010 Nov; 37(11):2165-8. PubMed ID: 21084819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A case of trastuzumab-resistant breast cancer responding to lapatinib/capecitabine therapy].
    Hayashi M; Orita M; Hironaka H; Morita N
    Gan To Kagaku Ryoho; 2014 Mar; 41(3):353-5. PubMed ID: 24743282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lapatinib plus capecitabine resolved human epidermal growth factor receptor 2-positive brain metastases.
    Glück S; Castrellon A
    Am J Ther; 2009; 16(6):585-90. PubMed ID: 19287304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid tumor shrinkage with lapatinib plus capecitabine in a patient with massive liver involvement.
    Giotta F; Latorre A; Cramarossa A; Simone G; Florio C; Oliva S; Lorusso V
    Tumori; 2013; 99(6):278e-81e. PubMed ID: 24503803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complete remission of recurrent breast cancer with multiple liver metastases after oral capecitabine and injected trastuzumab.
    Morohashi S; Odagiri H; Morohashi H; Kimura Y; Sasaki M
    Breast Cancer; 2007; 14(3):297-301. PubMed ID: 17690508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lapatinib plus capecitabine for HER2-positive advanced breast cancer: a multicentre study of Anatolian Society of Medical Oncology (ASMO).
    Cetin B; Benekli M; Turker I; Koral L; Ulas A; Dane F; Oksuzoglu B; Kaplan MA; Koca D; Boruban C; Yilmaz B; Sevinc A; Berk V; Uncu D; Harputluoglu H; Coskun U; Buyukberber S
    J Chemother; 2014 Oct; 26(5):300-5. PubMed ID: 24112786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Long-term response of liver metastases of breast cancer to capecitabine--case report].
    Macková D
    Klin Onkol; 2010; 23(1):46-8. PubMed ID: 20192074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II trial of a novel capecitabine dosing schedule in combination with lapatinib for the treatment of patients with HER2-positive metastatic breast cancer.
    Gajria D; Gonzalez J; Feigin K; Patil S; Chen C; Theodoulou M; Drullinsky P; D'Andrea G; Lake D; Norton L; Hudis CA; Traina TA
    Breast Cancer Res Treat; 2012 Jan; 131(1):111-6. PubMed ID: 21898114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early-onset brain metastases in a breast cancer patient after pathological complete response to neoadjuvant chemotherapy.
    Shimada K; Ishikawa T; Yoneyama S; Kita K; Narui K; Sugae S; Shimizu D; Tanabe M; Sasaki T; Chishima T; Ichikawa Y; Endo I
    Anticancer Res; 2013 Nov; 33(11):5119-21. PubMed ID: 24222158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metastatic breast cancer treated with lapatinib with a prolonged benefit: a case report and a review of therapeutic options available.
    Bianchi GV; Duca M; Sica L; Mariani G
    Tumori; 2013; 99(6):269e-72e. PubMed ID: 24503801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A Case of Effective Whole-Brain Irradiation and Lapatinib/Capecitabine Combination Therapy for HER2-Positive Breast Cancer with Multiple Brain Metastases].
    Shibasaki M; Tanabe A; Toda T; Sakata H; Ijichi M; Kusaka K; Bandai Y
    Gan To Kagaku Ryoho; 2015 Jun; 42(6):755-7. PubMed ID: 26199252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcomes in patients who received lapatinib plus capecitabine combination therapy for HER2-positive breast cancer with brain metastasis and a comparison of survival with those who received trastuzumab-based therapy: a study by the Anatolian Society of Medical Oncology.
    Kaplan MA; Isikdogan A; Koca D; Kucukoner M; Gumusay O; Yildiz R; Dayan A; Demir L; Geredeli C; Kocer M; Arslan UY; Inal A; Akman T; Coskun U; Sener N; Inanc M; Elkiran ET; Ozdemir NY; Durnalı AG; Suner A; Alici S; Tarhan MO; Boruban C; Oksuzoglu B; Urakci Z
    Breast Cancer; 2014 Nov; 21(6):677-83. PubMed ID: 23335064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of metastatic breast cancer with liver metastasis effectively treated with capecitabine and vinorelbine].
    Inari H; Chiba A; Inaba M; Ino H; Fukahori M; Yoshida A
    Gan To Kagaku Ryoho; 2009 Feb; 36(2):333-5. PubMed ID: 19223759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [An effective case of liver metastasis of breast cancer treated with capecitabine + docetaxel combination therapy using vitamin B6].
    Umeda T; Abe H; Cho H; Shimizu T; Mori T; Kubota Y; Kawai Y; Tanaka M; Kurumi Y; Tani T
    Gan To Kagaku Ryoho; 2010 Apr; 37(4):687-9. PubMed ID: 20414027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unusual long-lasting cutaneous complete response to lapatinib and capecitabine in a heavily pretreated HER2-positive plurimetastatic breast cancer patient.
    Pizzuti L; Sergi D; Barba M; Vici P
    Tumori; 2013; 99(3):e127-30. PubMed ID: 24158082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case of elderly metastatic breast cancer with a complete response to treatment with capecitabine and cyclophosphamide].
    Iida S; Furukawa K; Yokoyama T; Yanagihara K; Iwasaki R; Noguchi T; Tsuchiya S; Sugisaki Y; Naito Z; Tajiri T
    Gan To Kagaku Ryoho; 2007 Oct; 34(10):1697-700. PubMed ID: 17940394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase III randomized comparison of lapatinib plus capecitabine versus capecitabine alone in women with advanced breast cancer that has progressed on trastuzumab: updated efficacy and biomarker analyses.
    Cameron D; Casey M; Press M; Lindquist D; Pienkowski T; Romieu CG; Chan S; Jagiello-Gruszfeld A; Kaufman B; Crown J; Chan A; Campone M; Viens P; Davidson N; Gorbounova V; Raats JI; Skarlos D; Newstat B; Roychowdhury D; Paoletti P; Oliva C; Rubin S; Stein S; Geyer CE
    Breast Cancer Res Treat; 2008 Dec; 112(3):533-43. PubMed ID: 18188694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy of docetaxel combined capecitabine on metastatic breast cancer].
    Wang XX; Zhou ZM; Yuan ZY; Zhang DS; Shi YX; Jiang WQ
    Ai Zheng; 2007 Apr; 26(4):407-10. PubMed ID: 17430662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Successful treatment of trastuzumab-resistant HER2-positive breast cancer with extensive liver metastases using the combination of trastuzumab and capecitabine - a case report].
    Shigekawa T; Takeuchi H; Misumi M; Nakamiya N; Sugiyama M; Sugitani I; Fujiuchi N; Osaki A; Saeki T
    Gan To Kagaku Ryoho; 2013 Feb; 40(2):225-7. PubMed ID: 23411960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.